Abstract

The reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) has broad applications in regenerative medicine. The generation of self-organized retinal structures from these iPSCs offers the opportunity to study retinal development and model-specific retinal disease with patient-specific iPSCs and provides the basis for cell replacement strategies. In this study, we demonstrated that the major type of glial cells of the human retina, Müller cells, can be reprogrammed into iPSCs that acquire classical signature of pluripotent stem cells. These Müller glial cell-derived iPSCs were able to differentiate toward retinal fate and generate concomitantly retinal pigmented epithelial cells and self-forming retinal organoid structures containing retinal progenitor cells. Retinal organoids recapitulated retinal neurogenesis with differentiation of retinal progenitor cells into all retinal cell types in a sequential overlapping order. With a modified retinal maturation protocol characterized by the presence of serum and high glucose levels, our study revealed that the retinal organoids contained pseudolaminated neural retina with important features reminiscent of mature photoreceptors, both rod and cone subtypes. This advanced maturation of photoreceptors not only supports the possibility to use 3D retinal organoids for studying photoreceptor development but also offers a novel opportunity for disease modeling, particularly for inherited retinal diseases.

Highlights

  • Human pluripotent stem cells (PSCs) represent a valuable tool to study human neuronal development and neurodegenerative diseases and to develop future stem cell-based therapies [1]

  • We investigated the potential of human Müller glial cells (MGCs) to be reprogrammed into PSCs using the four reprogramming factors OCT3/4, SOX2, CMYC, and KLF4 delivered using nonintegrative Sendai viruses previously used for dermal fibroblast reprogramming [28]

  • Immunofluorescence analysis of human induced pluripotent stem cells (iPSCs) line-5f revealed the coexpression of transcription factors OCT4 and SOX2, and surface markers SSEA4 and TRA1-81 (Figures 1(d) and 1(e)), characteristic of pluripotent stem cells

Read more

Summary

Introduction

Human pluripotent stem cells (PSCs) represent a valuable tool to study human neuronal development and neurodegenerative diseases and to develop future stem cell-based therapies [1]. Many types of somatic cells, such as skin fibroblasts, blood cells, keratinocytes, or urine-derived cells, have been successfully used for reprogramming and the production of human iPSCs [1, 17]. Due to their high availability through noninvasive and routine sampling in clinical settings, blood and urine-derived cells have been considered as a preferred source for reprogramming. Independently of the initial somatic identity of reprogrammed cells, human iPSCs can be guided to differentiate into retinal organoids with relatively similar efficiency using different retinal differentiation protocols [11, 18,19,20,21].

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call